Embolization versus traditional surgery

When evaluating therapeutic approaches to benign prostatic hyperplasia, embolization is emerging as an alternative to conventional surgery, notably transurethral resection of the prostate (TURP). This method is distinguished by its minimally invasive nature, offering significant advantages. The embolization procedure is characterized by accelerated recovery for patients, reducing the risk of post-operative complications. It also allows shorter hospital stays, often on an outpatient basis in most cases.

Embolization, as an innovative option, offers a different approach to the management of benign prostatic hyperplasia. Compared with traditional surgical procedures, it guarantees a less invasive intervention, offering patients benefits such as rapid recovery, reduced risk of complications, and shorter hospital stays, sometimes even on an outpatient basis.

Preserving sexual function

A crucial point to emphasize is the preservation of sexual function after embolization. Unlike some surgical procedures, prostate embolization is associated with an exceptionally low rate of retrograde ejaculation. Furthermore, the results of the International Index of Erectile Function (IIEF) show a significant improvement in sexual life in 80% of patients.

No major complications

The study results underline the safety of the procedure, with no severe complications reported. This confirms embolization's position as a safe and well-tolerated treatment, offering patients a reassuring alternative to more invasive procedures.

Temporary side effects

Although some patients have reported short-term prostatic irritation, it's essential to note that these side effects are generally temporary. Furthermore, urinary tract infections treated with antibiotics and transient urinary blockages remain rare incidents.

Technological developments and ongoing research

As prostate embolization shows promise, ongoing research in the field is paving the way for technological developments. Continuous improvements in the technique can be anticipated, with a commitment to optimizing results and further personalizing treatment to the specific needs of each patient.

Conclusion: An optimistic future for BPH treatment

In conclusion, the positive results of this study suggest that prostate embolization can be considered as a first-line treatment option for patients suffering from benign prostatic hyperplasia. This minimally invasive technique, performed on an outpatient basis in most cases, offers high efficacy while preserving patients' sexual quality of life, making it an attractive treatment option for the future.

Prostatic artery embolization (PAE) is a non-surgical medical procedure used to treat benign prostatic hyperplasia (BPH). It selectively blocks the prostatic arteries with particles, reducing blood flow and causing the prostate to shrink.

EAP is performed to treat BPH symptoms such as urinary frequency, difficulty in urinating and incontinence. This less invasive alternative to surgery offers advantages such as faster recovery.

During the procedure, a catheter is inserted into the femoral artery to guide embolizing particles to the prostatic arteries. This procedure reduces the blood supply to the prostate, thereby promoting its shrinkage.

EAP offers advantages such as shorter hospital stay, faster recovery, and potentially fewer complications than traditional surgical treatments. It may be an option for patients who are not candidates for surgery.

Although considered safe, risks such as infection, bleeding or allergic reactions may occur. Patients may experience temporary symptoms such as pelvic pain or urinary irritation after the procedure.

Ideal candidates are usually men with moderate to severe BPH symptoms who have not responded to drug therapy. The final decision depends on the specialist's assessment.

Most patients can resume their normal activities after a few days, although temporary effects such as pain may be experienced. Full results may take a few weeks, with gradual improvement in urinary symptoms.

Certain medical conditions may render a patient ineligible, such as coagulation problems, active infections, or a history of severe allergies.

Although rare, some patients may experience temporary problems such as ejaculation disorders. The majority, however, report no significant changes in their sexual function.

Benefits may vary, but many patients experience a significant improvement in urinary symptoms that can last for several years. However, individual factors may influence the durability of results.

Insurance coverage varies according to location, type of insurance and the insurer's specific policy. It is advisable to check with your insurance company prior to the procedure to understand the level of coverage and any personal costs involved.